NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Quantitative analysis of CD38 expression on CD8 cells in HIV-1 infected patients.

Benito JM, Lopez M, Lozano S, Martinez P, Gonzalez-Lahoz J, Soriano V; International Conference on AIDS.

Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. ThPeA7148.

Instituto de Salud Carlos III (ISCIII), Madrid, Spain

BACKGROUND: In HIV-1 infection CD8+CD38+ T lymphocytes are strongly correlated with disease progression and have prognostic value independent of CD4+ counts. With HAART the level of this subset decreases, suggesting a relationship with the levels of plasma viremia(VL). Recently, the expression of CD38 on CD8 cells was proposed as a sensitive marker of viral replication.OBJECTIVE: To quantitatively analyze the expression of CD38 on CD8 cells(as number of CD38 molecules per CD8 cell) in chronic HIV-1 infection, and the effect of HAART on this parameter.METHODS:46 tretated and 96 untreated patients were included in the study. 7 HIV-negative subjects were included as control group. All treated patients had VL<50 cop/ml at the moment of the study. CD38 was quantified on CD8 cells by flow cytometry.RESULTS: CD4 counts were similar in both groups of patients (treated:436; untreated:463 cells/ul). Mean VL in the untreated group was 3.93 log(copies)/ml. CD38 on CD8 cells was higher in untreated when compared to treated patients and control group (6786, 2147 and 2768 molecules/cell respectively; p<0.01). In the untreated group CD38 expression and VL were strongly correlated (R=0.54, p<0.001). CD38 was also measured in the group of treated patients at different time points while on treatment (mean follow-up: 18.4 months). We compared levels of CD38 at three different time intervals after initiation of HAART. Although VL remained undetectable during the follow-up period in all patients, levels of CD38 decreased with time and were significantly lower after 18 months of therapy than in the first 12 months (2458 vs. 1608 molecules/cell respectively, p<0.05).CONCLUSION: Levels of CD38 on CD8 cells are increased in chronic HIV-1 infection and are strongly correlated with VL. This parameter normalizes under HAART, still decreasing over time when plasma VL is undetectable. This suggests that CD38 may be a marker of residual active virus replication.

Publication Types:
  • Meeting Abstracts
Keywords:
  • ADP-ribosyl Cyclase
  • Antigens, CD
  • Antiretroviral Therapy, Highly Active
  • Biological Markers
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes
  • HIV Infections
  • HIV-1
  • Humans
  • Viremia
  • Virus Replication
  • immunology
  • virology
Other ID:
  • GWAIDS0014610
UI: 102252108

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov